"Hyperglutamatergic Cortico-striato-thalamo-cortical Circuit" Breaker ...

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The brain circuits underlying tics in Tourette׳s syndrome (TS) are unknown but thought to involve cortico/amygdalo-striato-thalamo-cortical (CSTC) loop hyperactivity. We previously engineered a transgenic mouse "circuit model" of TS by expressing an artificial neuropotentiating transgene (encoding the cAMP-elevating, intracellular A1 subunit of cholera toxin) within a small population of dopamine D1 receptor-expressing somatosensory cortical and limbic neurons that hyperactivate cortico/amygdalostriatal glutamatergic output circuits thought to be hyperactive in TS and comorbid obsessive-compulsive (OC) disorders. As in TS, these D1CT-7 ("Ticcy") transgenic mice׳s tics were alleviated by the TS drugs clonidine and dopamine D2 receptor antagonists; and their chronic glutamate-excited striatal motor output was unbalanced toward hyperactivity of the motoric direct pathway and inactivity of the cataleptic indirect pathway. Here we have examined whether these mice׳s tics are countered by drugs that "break" sequential elements of their hyperactive cortical/amygdalar glutamatergic and efferent striatal circuit: anti-serotonoceptive and anti-noradrenoceptive corticostriatal glutamate output blockers (the serotonin 5-HT2a,c receptor antagonist ritanserin and the NE alpha-1 receptor antagonist prazosin); agmatinergic striatothalamic GABA output blockers (the presynaptic agmatine/imidazoline I1 receptor agonist moxonidine); and nigrostriatal dopamine output blockers (the presynaptic D2 receptor agonist bromocriptine). Each drug class alleviates tics in the Ticcy mice, suggesting a hyperglutamatergic CSTC "tic circuit" could exist in TS wherein cortical/amygdalar pyramidal projection neurons׳ glutamatergic overexcitation of both striatal output neurons and nigrostriatal dopaminergic modulatory neurons unbalances their circuit integration to excite striatothalamic output and create tics, and illuminating new TS drug strategies.

Keywords: Cortex; Dopamine; Glutamate; Somatosensory; Striatum; Tourette.

Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

PubMed Disclaimer

Publication types

• Research Support, N.I.H., Extramural Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Adrenergic alpha-1 Receptor Antagonists / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adrenergic alpha-1 Receptor Antagonists / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Animals Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Corpus Striatum / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Corpus Striatum / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Disease Models, Animal Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dopamine Agonists / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dopamine Agonists / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Female Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glutamic Acid / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mice Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mice, Inbred BALB C Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mice, Transgenic Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Nerve Net / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Nerve Net / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Serotonin 5-HT2 Receptor Antagonists / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Serotonin 5-HT2 Receptor Antagonists / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Somatosensory Cortex / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Somatosensory Cortex / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Thalamic Nuclei / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Thalamic Nuclei / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tics / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tics / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tourette Syndrome / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tourette Syndrome / metabolism* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Adrenergic alpha-1 Receptor Antagonists Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dopamine Agonists Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Serotonin 5-HT2 Receptor Antagonists Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glutamic Acid Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Grants and funding

• R03MH53553/MH/NIMH NIH HHS/United States
• T32DA07097/DA/NIDA NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program